DD157762A5 - Verfahren zur herstellung von stabilen,konzentrierten loesungen von cisplatin - Google Patents

Verfahren zur herstellung von stabilen,konzentrierten loesungen von cisplatin Download PDF

Info

Publication number
DD157762A5
DD157762A5 DD81228776A DD22877681A DD157762A5 DD 157762 A5 DD157762 A5 DD 157762A5 DD 81228776 A DD81228776 A DD 81228776A DD 22877681 A DD22877681 A DD 22877681A DD 157762 A5 DD157762 A5 DD 157762A5
Authority
DD
German Democratic Republic
Prior art keywords
cisplatin
solution
polyethylene glycol
molecular weight
solutions
Prior art date
Application number
DD81228776A
Other languages
German (de)
English (en)
Inventor
Murray A Kaplan
Alphonse P Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DD157762A5 publication Critical patent/DD157762A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DD81228776A 1980-03-31 1981-03-31 Verfahren zur herstellung von stabilen,konzentrierten loesungen von cisplatin DD157762A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (1)

Publication Number Publication Date
DD157762A5 true DD157762A5 (de) 1982-12-08

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81228776A DD157762A5 (de) 1980-03-31 1981-03-31 Verfahren zur herstellung von stabilen,konzentrierten loesungen von cisplatin

Country Status (30)

Country Link
JP (1) JPS56152415A (es)
KR (1) KR860000841B1 (es)
AR (1) AR225500A1 (es)
AT (1) AT370996B (es)
AU (1) AU541056B2 (es)
BE (1) BE888209A (es)
CA (1) CA1162479A (es)
CH (1) CH647481A5 (es)
CS (1) CS246051B2 (es)
DD (1) DD157762A5 (es)
DE (1) DE3112272A1 (es)
DK (1) DK158564C (es)
ES (1) ES500869A0 (es)
FI (1) FI70670C (es)
FR (1) FR2480605A1 (es)
GB (1) GB2074028B (es)
GR (1) GR72769B (es)
HU (1) HU183379B (es)
IE (1) IE51070B1 (es)
IL (1) IL62517A (es)
IT (1) IT1170838B (es)
LU (1) LU83270A1 (es)
NL (1) NL8101531A (es)
NO (1) NO156675C (es)
NZ (1) NZ196519A (es)
PH (1) PH17152A (es)
PT (1) PT72774B (es)
SE (1) SE455045B (es)
SU (1) SU1056893A3 (es)
ZA (1) ZA812084B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
ATE252372T1 (de) * 1996-08-23 2003-11-15 Sequus Pharm Inc Liposome enthaltend cisplatin
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
KR20200136997A (ko) 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 액체 약학적 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
CA1119954A (en) * 1978-05-30 1982-03-16 Edmund S. Granatek Aqueous solution of cisplatin

Also Published As

Publication number Publication date
IT8148090A0 (it) 1981-03-24
GB2074028B (en) 1983-09-21
SE455045B (sv) 1988-06-20
ZA812084B (en) 1982-04-28
JPS56152415A (en) 1981-11-26
NL8101531A (nl) 1981-10-16
ES8206545A1 (es) 1982-08-16
ATA150481A (de) 1982-10-15
NO811081L (no) 1981-10-01
JPS6360008B2 (es) 1988-11-22
IL62517A (en) 1984-01-31
IE810715L (en) 1981-09-30
FI70670B (fi) 1986-06-26
FR2480605A1 (fr) 1981-10-23
CA1162479A (en) 1984-02-21
HU183379B (en) 1984-04-28
AU6816681A (en) 1981-10-08
PT72774A (en) 1981-04-01
DK144281A (da) 1981-10-01
ES500869A0 (es) 1982-08-16
NO156675C (no) 1987-11-04
DE3112272C2 (es) 1990-09-27
FR2480605B1 (es) 1984-05-11
KR860000841B1 (ko) 1986-07-09
CS246051B2 (en) 1986-10-16
CH647481A5 (fr) 1985-01-31
FI810934L (fi) 1981-10-01
NZ196519A (en) 1983-06-17
KR830004849A (ko) 1983-07-20
BE888209A (fr) 1981-09-30
DE3112272A1 (de) 1982-04-29
PT72774B (en) 1982-11-16
SU1056893A3 (ru) 1983-11-23
AT370996B (de) 1983-05-25
GB2074028A (en) 1981-10-28
FI70670C (fi) 1986-10-06
NO156675B (no) 1987-07-27
IE51070B1 (en) 1986-09-17
AR225500A1 (es) 1982-03-31
DK158564C (da) 1990-11-05
AU541056B2 (en) 1984-12-13
GR72769B (es) 1983-12-02
IL62517A0 (en) 1981-05-20
LU83270A1 (fr) 1981-10-29
IT1170838B (it) 1987-06-03
SE8101990L (sv) 1981-11-13
PH17152A (en) 1984-06-13
DK158564B (da) 1990-06-11

Similar Documents

Publication Publication Date Title
DE3133443A1 (de) Mikrokristallines cisplatin
US4451447A (en) Pharmaceutical formulations
DE60209145T2 (de) Pharmazeutische formulierungen mit platinderivaten
CH655852A5 (de) Verfahren zur herstellung einer gefriergetrockneten pharmakologischen cis-platin-zusammensetzung.
CH641758A5 (de) Platin-diaminkomplexe und ihre verwendung zur herstellung von arzneimitteln zur krebsbehandlung.
DE3621844C2 (de) Injizierbare, Doxorubicin-enthaltende Lösung und Verfahren zur Herstellung derselben
EP0806955B1 (de) Enrofloxacin-injektions- oder infusionslösungen
DE3112272C2 (es)
DE3000743C2 (de) Arzneipräparat auf der Basis eines Salzes der Acetylsalicylsäure und einer basischen Aminosäure
DE2906700C2 (de) Pharmazeutisches Mittel
DE3740588C2 (de) Temperaturstabiles Breitband-Antibiotikum
EP2047855B1 (de) Antitumorale, antibakterielle und antivirale pharmazeutische zusammensetzung (varianten)
DE3752368T2 (de) Doxorubicin enthaltende einspritzbare gebrauchsfertige Lösungen gegen Krebs
DE112004001563T5 (de) Säure-haltige Oxaliplatin-Formulierungen
CH647677A5 (de) 4'-(acridinylamino)-methansulfon-anisidid enthaltende pharmazeutische zusammensetzung.
DE3536745C2 (es)
EP0147851A2 (de) Wasserlösliche Formen von Polyenantibiotika und Verfahren zu ihrer Herstellung
DE2546474A1 (de) Injizierbares pharmazeutisches thyroxinpraeparat und verfahren zu dessen herstellung
DE69921832T2 (de) Pharmazeutische zusammensetzungen mit antitumoraler wirkung auf basis von carboplatin
DE60318310T2 (de) Injizierbare arzneimittel die ein anthracendionderivat, mit antitumoraktivität, enthalten
DE2501805A1 (de) Arzneimittelzubereitungen und verfahren zu ihrer herstellung
DE3044736C2 (es)
EP0054215B1 (de) (8-(Dialkylaminoalkoxy)-coffein)-Platinkomplexe, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE3720654A1 (de) Verfahren zur verhinderung der verfaerbung waessriger cefmenoxim-praeparate
DE3645281C2 (de) Injizierbare, 4-Desmethoxy-daunorubicin- oder Daunorubicin enthaltende Lösung und Verfahren zur Herstellung derselben

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee